Remacemide HC1 and its metabolite, FPL 12495AA, limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell culture
- 1 February 1996
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 23 (1) , 1-14
- https://doi.org/10.1016/0920-1211(95)00053-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channelsPublished by Elsevier ,1992
- Preclinical profile of the anticonvulsant remacemide and its enantiomers in the ratEpilepsy Research, 1991
- Preclinical profile of stereoisomers of the anticonvulsant remacemide in miceEpilepsy Research, 1991
- Carbamazepine blocks NMDA-activated currents in cultured spinal cord neuronsNeuroReport, 1990
- The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK‐801: a voltage clamp study on neuronal cells in cultureBritish Journal of Pharmacology, 1989
- Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerationsEpilepsy Research, 1988
- Modulated anticonvulsant block of sodium channels in nerve and muscleEuropean Journal of Pharmacology, 1983
- Calcium- and sodium-dependent action potentials of mouse spinal cord and dorsal root ganglion neurons in cell culture.Journal of Neurophysiology, 1982
- Anticonvulsant activity of (+)‐5‐methyl‐10, 11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Development Research, 1982
- Antiepileptic Drug Development: II. Anticonvulsant Drug ScreeningEpilepsia, 1978